Amanda N. King

<i>CYP24A1</i> Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma

Guoan Chen, So Hee Kim, Amanda N. King et al. · Clinical Cancer Research · 2010 · 109 citations · Full text

Medicine, Oncology, Pharmacology +12

Characterization of vitamin D receptor (VDR) in lung adenocarcinoma

So Hee Kim, Guoan Chen, Amanda N. King et al. · Lung Cancer · 2012 · 67 citations · Full text

Medicine, Cancer Biology, Oncology +14

Audit of three antimuscarinic drugs for managing retained secretions

Andrew Hughes, Andrew Wilcock, R Corcoran et al. · Palliative Medicine · 2000 · 46 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD)

H. Ludlam, I. K. Barton, L. O. White et al. · Journal of Antimicrobial Chemotherapy · 1990 · 35 citations

Medicine, Microbiology, Pharmacotherapy +8

In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases

Amanda N. King, Kevin Shannon, Ian Phillips · Antimicrobial Agents and Chemotherapy · 1980 · 30 citations · Full text

Life Sciences, Microbiology, Pharmacology +17